Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Leyden Labs logo — Freeing humanity from the burden of respiratory viruses

Leyden Labs

Freeing humanity from the burden of respiratory viruses

Founded 2020 The Netherlands The Netherlands 80 employees Unknown Total: $342.50M Biotechnology, Health and Wellness +1

General Information

Company Name Leyden Labs
Founded Year 2020
Location The Netherlands The Netherlands +1
Employees 80
Industries Biotechnology, Health and Wellness, Life Sciences
Funding Stage Unknown
Social

Get notified when Leyden Labs moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Acquisition Made Sep 10, 2026

Leyden Labs completed the acquisition of RIGImmune Inc. earlier this year, integrating its assets and personnel into the company.

Regulatory Approval Sep 09, 2026

Leyden Labs announced positive phase 1 results for RIG-101, supporting its advancement into phase 2 clinical development.

In The News Sep 03, 2026

Featured on Tech: The Netherlands' top-funded tech companies in H1 2026

Actively Hiring Aug 17, 2026

Hiring for 1 position in the last 30 days.

Get alerts when Leyden Labs shows new signals

AI Insight

Bounce Watch AI
2 weeks ago

Leyden Labs recently closed a significant €40 million Late VC funding round in June 2026, with the European Innovation Council (EIC) Fund — recognized as Europe's most active investor — among its key participants. This substantial investment, which also included the Bill & Melinda Gates Foundation, signals robust confidence in their broad-spectrum intranasal antiviral platform and its potential for global public health impact. The continuous influx of capital from diverse strategic investors empowers Leyden Labs to further accelerate its clinical development and market readiness for respiratory virus prevention.

Signal Types
Funding Market Recognition
Strategic Labels
Late-Stage Funding Biotech Growth Strategic Partnerships
Next Move: Clinical Trials
·
Impact: 9/10
·
Ideal For: Late-Stage Biotech VCs — Public Health Focus

About Leyden Labs

Leyden Labs is a Netherlands-based company founded in 2020, operating within the Biotechnology, Health and Wellness, and Life Sciences industries. Its mission, succinctly put as “Freeing humanity from the burden of respiratory viruses,” encapsulates its focus on developing intranasal solutions aimed at providing immediate protection against a broad spectrum of respiratory viruses, including influenza and coronavirus variants.

The company’s innovative approach targets viral commonalities to safeguard humanity from both existing and emerging threats. This strategy is supported by a dynamic team comprising seasoned biotech veterans and new talent committed to unconventional thinking.

Leyden Labs last secured a €40.00M late VC investment on 01 June 2026, backed by prestigious investors like the Bill & Melinda Gates Foundation, Invest-NL, ClavystBio, EIC Fund, and reanfoundation.org, underscoring strong confidence in its journey to revolutionize global health security.

Taxonomy: intranasal products, respiratory viruses, virus prevention, influenza, coronavirus, viral families, infectious disease, immunology, drug development, public health, preventive medicine, innovative healthcare, antiviral products, biotech innovation

Services & Products

Development of nasal sprays for respiratory viruses
Clinical testing of antiviral compounds
Research in mucosal immunity and antibody modification

Target Customers

Healthcare providers Pharmaceutical companies Governments and public health institutions Individuals seeking preventive health measures

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Late Vc •••••• 5
Investor Investor Investor
•••• •••• 		01 Jun 2026
Grant •••••• 2
Investor
•••• •••• 		01 Oct 2025
Debt Financing •••••• 1 •••• •••• 01 Jun 2025
Late Vc •••••• 10
Investor Investor Investor Investor Investor Investor Investor Investor Investor Investor
01 Jan 2025
Grant •••••• 1
Investor
01 Oct 2024

View All 7 Funding Rounds

Latest News

View All
22 techbio soonicorns ready to cross the $1bn threshold — Sifted
22 techbio soonicorns ready to cross the $1bn threshold
Sifted Feb 22, 2024
Mews leads top 10 funding rounds in rough quarter for Dutch tech — Thenextweb
Mews leads top 10 funding rounds in rough quarter for Dutch tech
Thenextweb Apr 10, 2025
Funding focus: Biotech dominates Netherlands’ top 10 rounds in H1 2025 — Thenextweb
Funding focus: Biotech dominates Netherlands’ top 10 rounds in H1 2025
Thenextweb Jul 09, 2025
Leyden Labs secures €40 million to develop intranasal protection against influenza and coronaviruses — Eu-startups
Leyden Labs secures €40 million to develop intranasal protection against influenza and coronaviruses
Eu-startups Jun 25, 2026
Top 10 most active investors in Europe in 2026 – so far — Eu-startups
Top 10 most active investors in Europe in 2026 – so far
Eu-startups Jul 20, 2026
The Netherlands' top-funded tech companies in H1 2026 — Tech
The Netherlands' top-funded tech companies in H1 2026
Tech Sep 03, 2026

Leyden Labs Alternatives & Competitors

View All Alternatives
Leyden Labs vs
Catholic Charities USA
Catholic Charities USA United States

Working to Reduce Poverty in America

Grant
2993 employees
Health Care
Compare Leyden Labs vs Catholic Charities USA
Leyden Labs vs
JobSearchDigest.com
JobSearchDigest.com

Job Search Digest is an online career service that provides job candidates with a targeted database...

1 employees
Financial Services
Leyden Labs vs
TalentCore Employment Services, Inc.
TalentCore Employment Services, Inc. United States

The Center for Talent

9 employees
Also compare with: Leyden Labs vs HackerTrail - Recruitment Solutions HackerTrail - Recruitment Solutions Leyden Labs vs CTC People CTC People View all alternatives

FAQ About Leyden Labs

Freeing humanity from the burden of respiratory viruses
Leyden Labs was founded in 2020.
Leyden Labs is headquartered in The Netherlands.
Leyden Labs operates in the following industries: Biotechnology, Health and Wellness, Life Sciences.
Leyden Labs has approximately 80 employees.
Leyden Labs has completed 7 funding rounds, raising a total of $342.50M. The latest funding stage is Unknown.
Leyden Labs offers: Development of nasal sprays for respiratory viruses, Clinical testing of antiviral compounds, Research in mucosal immunity and antibody modification.
Top alternatives and competitors to Leyden Labs include Catholic Charities USA, JobSearchDigest.com, TalentCore Employment Services, Inc., Evergreen Goodwill of Northwest Washington, Hiring People. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Leyden Labs and Catholic Charities USA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Leyden Labs and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy